scholarly journals A novel catalytic mechanism for ATP hydrolysis employed by the N-terminal nucleotide-binding domain of Cdr1p, a multidrug ABC transporter of Candida albicans

2008 ◽  
Vol 1778 (10) ◽  
pp. 2143-2153 ◽  
Author(s):  
Versha Rai ◽  
Manisha Gaur ◽  
Antresh Kumar ◽  
Sudhanshu Shukla ◽  
Sneha Sudha Komath ◽  
...  
2005 ◽  
Vol 24 (11) ◽  
pp. 1901-1910 ◽  
Author(s):  
Jelena Zaitseva ◽  
Stefan Jenewein ◽  
Thorsten Jumpertz ◽  
I Barry Holland ◽  
Lutz Schmitt

Author(s):  
Ljuvica Kolich ◽  
Ya-Ting Chang ◽  
Nicolas Coudray ◽  
Sabrina I. Giacometti ◽  
Mark R. MacRae ◽  
...  

ABC transporters facilitate the movement of a diverse array of molecules across cellular membranes, using power from ATP hydrolysis. While the overall mechanism of the transport cycle has been characterized in detail for several important members of this transporter family, it is less well understood how the activity of ABC transporters is regulated in the cell post-translationally. Here we report the X-ray crystal structure of MlaFB from E. coli, an ABC nucleotide binding domain (MlaF) in complex with its putative regulatory subunit (MlaB). MlaFB constitutes the cytoplasmic portion of the larger MlaFEDB ABC transporter complex, which drives phospholipid transport across the bacterial envelope and is important for maintaining the integrity of the outer membrane barrier. Our data show that the regulatory subunit MlaB, a STAS domain protein, binds to the nucleotide binding domain and is required for its stability. Our structure also implicates a unique C-terminal tail of the ABC subunit, MlaF, in self-dimerization. Both the C-terminal tail of MlaF and the interaction with MlaB are required for the proper assembly of the MlaFEDB complex and its function in cells. This work leads to a new model for how the activity of an important bacterial lipid transporter may be regulated by small binding proteins, and raises the possibility that similar regulatory mechanisms may exist more broadly across the ABC transporter family, from bacteria to humans.


Biochemistry ◽  
2006 ◽  
Vol 45 (49) ◽  
pp. 14726-14739 ◽  
Author(s):  
Versha Rai ◽  
Manisha Gaur ◽  
Sudhanshu Shukla ◽  
Suneet Shukla ◽  
Suresh V. Ambudkar ◽  
...  

Biochemistry ◽  
2014 ◽  
Vol 53 (46) ◽  
pp. 7148-7159 ◽  
Author(s):  
T. Reid Alderson ◽  
Jin Hae Kim ◽  
Kai Cai ◽  
Ronnie O. Frederick ◽  
Marco Tonelli ◽  
...  

2007 ◽  
Vol 28 (5) ◽  
pp. 1841-1850 ◽  
Author(s):  
Zhengmao Ye ◽  
John D. Lich ◽  
Chris B. Moore ◽  
Joseph A. Duncan ◽  
Kristi L. Williams ◽  
...  

ABSTRACT The recently discovered nucleotide binding domain-leucine rich repeat (NLR) gene family is conserved from plants to mammals, and several members are associated with human autoinflammatory or immunodeficiency disorders. This family is defined by a central nucleotide binding domain that contains the highly conserved Walker A and Walker B motifs. Although the nucleotide binding domain is a defining feature of this family, it has not been extensively studied in its purified form. In this report, we show that purified Monarch-1/NLRP12, an NLR protein that negatively regulates NF-κB signaling, specifically binds ATP and exhibits ATP hydrolysis activity. Intact Walker A/B motifs are required for this activity. These motifs are also required for Monarch-1 to undergo self-oligomerization, Toll-like receptor- or CD40L-activated association with NF-κB-inducing kinase (NIK) and interleukin-1 receptor-associated kinase 1 (IRAK-1), degradation of NIK, and inhibition of IRAK-1 phosphorylation. The stable expression of a Walker A/B mutant in THP-1 monocytes results in increased production of proinflammatory cytokines and chemokines to an extent comparable to that in cells in which Monarch-1 is silenced via short hairpin RNA. The results of this study are consistent with a model wherein ATP binding regulates the anti-inflammatory activity of Monarch-1.


Sign in / Sign up

Export Citation Format

Share Document